Navigation Links
Proscia Takes Aim at Cancer with Artificial Intelligence and Digital Pathology Software
Date:7/26/2017

Proscia Inc., a software solutions provider for digital pathology, announced today its CEO David West Jr. will be a featured panelist at 2017 MedCity CONVERGE. His talk, “The Davids vs. the Cancer Goliath,” will discuss how Proscia and other leading startups in the diagnostics, biopharmaceuticals, medical technology, and emerging technology (AI, VR, Big Data) sectors are taking aim at cancer diagnosis and research. Proscia will also be featured as part of the “Startup Showcase” to further demonstrate the capabilities of its digital pathology software and image analysis algorithms. MedCity CONVERGE will take place on July 31 – August 1, 2017 in Philadelphia, Pennsylvania.

“We are honored to partake in thought-provoking discussions on how innovation in science and technology can take on one of healthcare’s greatest challenges, cancer,” said West. “At Proscia we are committed to developing digital pathology software that will bring cancer diagnosis and research out of the Stone Age and into the digital realm, and ultimately allow pathologists to make more informed diagnoses and improve patient outcomes.”

MedCity CONVERGE  is a two-day executive summit that gathers innovative thought leaders from across all healthcare sectors to provide actionable insight on where medical innovation is heading. This year, MedCity CONVERGE focuses on one of healthcare’s greatest challenges: cancer. Technology disruptors, along with payers, providers, life science companies, and venture capitalists, will all gather to discuss how AI, Big Data and Precision Medicine are changing the game in cancer. The MedCity CONVERGE Startup Showcase features companies taking some of the most innovative approaches and/or trying to solve some of the biggest problems in healthcare.

“Proscia is building software that will augment the work of the pathologist through deep learning and image-based diagnostics, which will revolutionize the way that the field treats cancer,” West adds. “Our goal is to educate leaders in the healthcare sector on ways they can take advantage of our groundbreaking software to more efficiently run their labs.”

About Proscia
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed, and quality of pathology diagnostics and research. To learn more, please visit http://www.proscia.com.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14537756.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Proscia’s Artificial Intelligence to Transform Pathology Labs and Drive Their Digital Evolution
2. Frost & Sullivan Identifies Proscia as a Game-changing Company in Cloud-based Digital Pathology
3. Proscia Takes on Subjectivity in Pathology Through AI Innovation
4. Proscia and Huron Digital Pathology Partner to Provide Seamlessly Integrated Digital Pathology Scanner-Software Solution
5. Proscia Partners with Samsung Medical Center to Research Predictive Medicine in Cancer Diagnosis and Treatment
6. Proscia Announces Massive Dataset Migration Service to Accelerate Transfer of Large-Scale Digital Pathology Image Data to the Cloud
7. American Diabetes Association Takes An Ostrich Approach to Brittle Diabetes
8. Sigma Blood Systems CEO Max Doleh Takes Message on Value of Quality and Process Management Software to Global Audiences
9. Electronic Data Capture System ClinCapture Takes Home Two Bronze Stevie Awards for Best New Product of The Year 2016
10. Stockton Takes First Step Into The U.S. Market
11. Ping An Ventures Takes Equity Stake in 20/20 GeneSystems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global ... industries to improve patient outcomes and quality of life, will now be offering ... being attributed to new regulatory requirements for all new drug products, including the ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
Breaking Biology Technology:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):